Cite
HARVARD Citation
Levy, P. et al. (2019). Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective. Journal of market access & health policy. 7 (1), p. . [Online].